CAROLINE DIGIACOMO: Open Payments
NPI 1922646215 · AUSTELL, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$577 in 24 payments from 13 companies in 2025. Trend: 2023 $549 · 2024 $1,228 · 2025 $577
Food & beverage: $577
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $100 |
| ACADIA Pharmaceuticals Inc | 4 | $93 |
| ABBVIE INC. | 4 | $92 |
| Teva Pharmaceuticals USA, Inc. | 2 | $49 |
| GENZYME CORPORATION | 1 | $43 |
| Neurocrine BioSciences, Inc. | 1 | $37 |
| Lundbeck LLC | 1 | $34 |
| GE HEALTHCARE | 1 | $33 |
| Biogen, Inc. | 1 | $22 |
| Grifols USA, LLC | 1 | $21 |
Products named: KESIMPTA, NUPLAZID, VYALEV, AUSTEDO XR, INGREZZA, QULIPTA, REXULTI, TYSABRI.
Industry payments across GA — which companies pay providers there.
